Clinical Applications
l Early Diagnosis of AMI
CK-MB can be used for early diagnosis and risk stratification of AMI, it is detectable within 3–8 h after the occurence of AMI.
l Coronary artery bypass grafting (CABG) prognosis with Non ST segment elevation(NSTE) myocardial infarction acute coronary syndromes(ACS)
CK-MB elevations after CABG are independently associated with increased risk of mortality in patients with NSTE ACS.
l Percutaneous coronary intervention (PCI) prognosis
The value of post-procedural cardiac biomarkers such as CK-MB increased following PCI, the level of CK-MB was associated with impaired outcome.
